Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
23 mars 2023 10h46 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching...
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
07 mars 2023 03h38 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Amydis Announces Enrollment of Cerebral Amyloid Angiopathy Participants in Phase 1/2a Retinal Tracer Trial
21 févr. 2023 05h00 HE
|
Amydis, Inc.
SAN DIEGO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease biomarkers in the eye, today...
Burning Rock provides an update on 2022 revenue guidance
17 janv. 2023 20h37 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
03 janv. 2023 09h25 HE
|
Burning Rock Biotech Limited
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...
Burning Rock Reports Third Quarter 2022 Financial Results
15 nov. 2022 21h20 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Amydis Awarded Third Grant From The Michael J. Fox Foundation To Support First-In-Human Study of a Retinal Tracer for Parkinson’s Disease
27 oct. 2022 07h00 HE
|
Amydis, Inc.
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of diagnostic drug candidates targeting molecular biomarkers in the eye, today...
Burning Rock Reports Second Quarter 2022 Financial Results
31 août 2022 05h29 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Avricore Health Reports Second-Quarter 2022 Results
29 août 2022 08h30 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. ...
Fountain Life Selected as Official Preventative Healthcare Provider for Invited, Formerly ClubCorp, Expanding Mission to Enhance Longevity and Performance
20 juil. 2022 09h00 HE
|
Fountain Life
NAPLES, Fla., July 20, 2022 (GLOBE NEWSWIRE) -- Fountain Life, a preventative medicine company committed to transforming global healthcare from reactive to proactive, is excited to announce its...